Vol , Issue Date of Publication: July 01, 2011
DOI: https://doi.org/10.20529/IJME.2011.074

Views
, PDF Downloads:

More questions than answers

A Mohan
Abstract:
The past two decades have seen the emergence of third world countries as important sites for drug trials and related clinical research sponsored by the pharmaceutical industry. As the authors of the report under review have noted, “fast recruitment of trial participants, presence of a broad spectrum of diseases, availability of human resources and technical skills, different ethnic responses to drugs and the availability of treatment naïve population” are powerful drivers of thisphenomenon. In addition to such off-shoring, the authors have also drawn attention to outsourcing of trials to clinical research organisations (CROs). Considering the potential for abuse of rights and ethical deviations, such a study of this phenomenon was a pressing need.


Copyright and license
©Indian Journal of Medical Ethics 2016: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0),
which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.

Full Text

HTML | PDF
Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation